Cristal Therapeutics pulls in funding
Cristal Therapeutics, a Dutch life sciences company focused on treating cancer and other diseases, has raised 12.8 million euros in financing. The investors included Aglaia BioMedical Ventures, Belgian DROIA Oncology Ventures, Chemelot Ventures, BioGeneration Ventures, Utrecht University Holding and Nedermaas Hightech Ventures.
19 January 2017•1 min read
